Surgery-Induced Weight Loss and Changes in Hormonally Active Fibroblast Growth Factors: a Systematic Review and Meta-Analysis

Obes Surg. 2020 Oct;30(10):4046-4060. doi: 10.1007/s11695-020-04807-7.

Abstract

This systematic review and meta-analysis was performed to investigate the possible changes of FGF-19 and FGF-21 after bariatric surgery (BS). Electronic databases including PubMed and Scopus were systematically searched up to February 2020 to identify pertinent studies. A total of 25 different studies were included. The overall pooled analysis identified that BS caused a significant increase in FGF-19, but had no significant effect on FGF-21. For FGF-19, this finding was supported in the subgroup analyses. For FGF-21, Roux-en-Y gastric bypass (RYGB) surgery significantly increased FGF-21 levels, whereas, in studies with follow-up duration ≥ 1 year, FGF-21 levels decreased significantly. BS reduces circulating concentration of FGF-19, but might increase FGF-21 after RYGB or decrease FGF-21 after ≥ 1 year.

Keywords: Bariatric surgery; FGF-19; FGF-21; Fibroblast growth factor; Obesity; Weight loss.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Bariatric Surgery*
  • Fibroblast Growth Factors
  • Gastric Bypass*
  • Humans
  • Obesity, Morbid* / surgery
  • Weight Loss

Substances

  • Fibroblast Growth Factors